Brief: Renovorx Says On February 21, Co Got Notice From Nasdaq
23/02/2024 23:48
Feb 23 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX INC - ON FEBRUARY 21, CO GOT NOTICE FROM NASDAQ
THAT CO
HAD, AS OF DATE OF NOTICE, FAILED TO MEET MINIMUM STOCKHOLDERS'
EQUITY REQUIREMENT
Source text for Eikon: ID:n0001493152-24-007693
Further company coverage: RNXT.O
((reuters.briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: RenovoRx Gets FDA Orphan Drug Designation For Oxaliplatin To Treat Pancreatic Cancer
RenovoRx Q1 revenue rises as number of active cancer centers increase
RenovoRx 2025 net loss widens on higher operating expenses
Brief: RenovoRx FY Net Income USD -11.168 Million
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies